Myomo (MYO) Revenue (QoQ) (2016 - 2025)
Myomo (MYO) Revenue (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Myomo | 42.59 Mn | 23.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.54% |
| Jun 30, 2025 | -1.83% |
| Mar 31, 2025 | -18.53% |
| Dec 31, 2024 | 31.07% |
| Sep 30, 2024 | 22.43% |
| Jun 30, 2024 | 100.32% |
| Mar 31, 2024 | -21.07% |
| Dec 31, 2023 | -6.36% |
| Sep 30, 2023 | -14.75% |
| Jun 30, 2023 | 72.88% |
| Mar 31, 2023 | -14.72% |
| Dec 31, 2022 | 1.85% |
| Sep 30, 2022 | 7.90% |
| Jun 30, 2022 | -4.92% |
| Mar 31, 2022 | -4.06% |
| Dec 31, 2021 | -8.04% |
| Sep 30, 2021 | 41.22% |
| Jun 30, 2021 | 32.86% |
| Mar 31, 2021 | -38.35% |
| Dec 31, 2020 | 96.71% |